FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283162273> ?p ?o ?g. }

• W4283162273 abstract "Concurrent chemoradiotherapy (CCRT) has become the cornerstone of treatment for patients with locally advanced non-small cell lung cancer (LA-NSCLC). The aim of this study was to compare the efficacies and toxicities of different CCRT regimens in the treatment of LA-NSCLC by adopting a network meta-analysis (NMA).An exhaustive search of PubMed, EMBASE, Web of Science, and the Cochrane Central Register of Controlled Trials (CENTRAL) was conducted to identify relevant studies from inception to October 1, 2020. Direct and indirect evidence was combined to calculate the odds radios (ORs) and 95% confidence intervals (CIs), as well as to plot the surface under the cumulative ranking (SUCRA) curves. Cluster analyses were adopted to compare the efficacies and toxicities of different CCRT regimens according to the similarity of 2 variables. Publication bias was detected by comparison-adjusted funnel plots.Twenty-two studies were enrolled in this NMA, including 18 regimens: CCRT (cisplatin + etoposide), CCRT (carboplatin + paclitaxel), CCRT (pemetrexed + carboplatin), CCRT (pemetrexed + cisplatin), CCRT (docetaxel + cisplatin), CCRT (S-1 + cisplatin), CCRT (mitomycin + vindesine + cisplatin), CCRT (cisplatin + vinorelbine), CCRT (cisplatin), CCRT (etoposide + cisplatin + amifostine), RT, CCRT (5-FU), CCRT (paclitaxel + cisplatin), CCRT (irinotecan + carboplatin), CCRT (nedaplatin), CCRT (carboplatin + etoposide), CCRT (paclitaxel), and CCRT (carboplatin). The results indicated that the regimens with CCRT (cisplatin + etoposide), CCRT (carboplatin + paclitaxel), CCRT (pemetrexed + cisplatin), CCRT (S-1 + cisplatin), and CCRT (cisplatin + vinorelbine) had relatively better efficacies compared with other regimens. As for toxicities of different CCRT regimens, the CCRT (carboplatin + paclitaxel), CCRT (pemetrexed + cisplatin), and CCRT (docetaxel + cisplatin) were relatively lower.Our study demonstrated that CCRT (pemetrexed + cisplatin) and CCRT (carboplatin + paclitaxel) might be the best options for the treatment of LA-NSCLC, and CCRT (pemetrexed + cisplatin) had the highest 3-year overall survival (OS) rate." @default.
• W4283162273 created "2022-06-21" @default.
• W4283162273 creator A5013414141 @default.
• W4283162273 creator A5028419939 @default.
• W4283162273 creator A5061620302 @default.
• W4283162273 date "2022-06-20" @default.
• W4283162273 modified "2023-10-05" @default.
• W4283162273 title "A network meta-analysis for efficacies and toxicities of different concurrent chemoradiotherapy regimens in the treatment of locally advanced non-small cell lung cancer" @default.
• W4283162273 cites W1763640999 @default.
• W4283162273 cites W1883230463 @default.
• W4283162273 cites W1930978022 @default.
• W4283162273 cites W1984733361 @default.
• W4283162273 cites W1984971509 @default.
• W4283162273 cites W2016717983 @default.
• W4283162273 cites W2019626224 @default.
• W4283162273 cites W2032034907 @default.
• W4283162273 cites W2035412694 @default.
• W4283162273 cites W2040478900 @default.
• W4283162273 cites W2049286103 @default.
• W4283162273 cites W2055889594 @default.
• W4283162273 cites W2062009962 @default.
• W4283162273 cites W2062581935 @default.
• W4283162273 cites W2070489918 @default.
• W4283162273 cites W2073882297 @default.
• W4283162273 cites W2073979951 @default.
• W4283162273 cites W2080373386 @default.
• W4283162273 cites W2086812757 @default.
• W4283162273 cites W2090406314 @default.
• W4283162273 cites W2091808438 @default.
• W4283162273 cites W2092283662 @default.
• W4283162273 cites W2104701073 @default.
• W4283162273 cites W2109204419 @default.
• W4283162273 cites W2120285723 @default.
• W4283162273 cites W2126432666 @default.
• W4283162273 cites W2129675268 @default.
• W4283162273 cites W2134417792 @default.
• W4283162273 cites W2134667653 @default.
• W4283162273 cites W2136240226 @default.
• W4283162273 cites W2142764975 @default.
• W4283162273 cites W2145653040 @default.
• W4283162273 cites W2152939220 @default.
• W4283162273 cites W2153169173 @default.
• W4283162273 cites W2153477391 @default.
• W4283162273 cites W2160797118 @default.
• W4283162273 cites W2161763362 @default.
• W4283162273 cites W2165410491 @default.
• W4283162273 cites W2166025830 @default.
• W4283162273 cites W2170768661 @default.
• W4283162273 cites W2177500163 @default.
• W4283162273 cites W2263280562 @default.
• W4283162273 cites W2272984102 @default.
• W4283162273 cites W2273884170 @default.
• W4283162273 cites W2511367473 @default.
• W4283162273 cites W2518611515 @default.
• W4283162273 cites W2537217940 @default.
• W4283162273 cites W2563204578 @default.
• W4283162273 cites W2568357966 @default.
• W4283162273 cites W2581880534 @default.
• W4283162273 cites W2618641368 @default.
• W4283162273 cites W2738647444 @default.
• W4283162273 cites W2917837889 @default.
• W4283162273 cites W2995072671 @default.
• W4283162273 cites W2999417355 @default.
• W4283162273 cites W3104847433 @default.
• W4283162273 cites W4238956621 @default.
• W4283162273 cites W4249552602 @default.
• W4283162273 doi "https://doi.org/10.1186/s12885-022-09717-8" @default.
• W4283162273 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35725420" @default.
• W4283162273 hasPublicationYear "2022" @default.
• W4283162273 type Work @default.
• W4283162273 citedByCount "5" @default.
• W4283162273 countsByYear W42831622732023 @default.
• W4283162273 crossrefType "journal-article" @default.
• W4283162273 hasAuthorship W4283162273A5013414141 @default.
• W4283162273 hasAuthorship W4283162273A5028419939 @default.
• W4283162273 hasAuthorship W4283162273A5061620302 @default.
• W4283162273 hasBestOaLocation W42831622731 @default.
• W4283162273 hasConcept C126322002 @default.
• W4283162273 hasConcept C143998085 @default.
• W4283162273 hasConcept C2776256026 @default.
• W4283162273 hasConcept C2776694085 @default.
• W4283162273 hasConcept C2777240266 @default.
• W4283162273 hasConcept C2778203143 @default.
• W4283162273 hasConcept C2778239845 @default.
• W4283162273 hasConcept C2781190966 @default.
• W4283162273 hasConcept C2781451048 @default.
• W4283162273 hasConcept C71924100 @default.
• W4283162273 hasConceptScore W4283162273C126322002 @default.
• W4283162273 hasConceptScore W4283162273C143998085 @default.
• W4283162273 hasConceptScore W4283162273C2776256026 @default.
• W4283162273 hasConceptScore W4283162273C2776694085 @default.
• W4283162273 hasConceptScore W4283162273C2777240266 @default.
• W4283162273 hasConceptScore W4283162273C2778203143 @default.
• W4283162273 hasConceptScore W4283162273C2778239845 @default.
• W4283162273 hasConceptScore W4283162273C2781190966 @default.
• W4283162273 hasConceptScore W4283162273C2781451048 @default.
• W4283162273 hasConceptScore W4283162273C71924100 @default.
• W4283162273 hasIssue "1" @default.
• W4283162273 hasLocation W42831622731 @default.
• W4283162273 hasLocation W42831622732 @default.

• next